conolidine - An Overview
Andy Chevigné and his group, RTI-5152-12 is postulated to boost the levels of opioid peptides that bind to classical opioid receptors during the brain, leading to heightened painkilling action. The LIH-RTI research teams recognized a collaboration agreement and filed a joint patent software in December 2020.Conolidine CONOCB2™, that has been cod